Package 59762-0935-3

{"route": ["ORAL"], "spl_id": "3ed9078b-c9be-42a0-a7b4-1072bf475363", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "upc": ["0359762093530"], "unii": ["JFU09I87TR"], "rxcui": ["349434", "349435", "465355"], "spl_set_id": ["b8de04a0-238d-4e0b-b0d9-7f7878b149d4"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (59762-0935-3)  / 75 mL in 1 BOTTLE", "package_ndc": "59762-0935-3", "marketing_start_date": "20131216"}], "brand_name": "Voriconazole", "product_id": "59762-0935_3ed9078b-c9be-42a0-a7b4-1072bf475363", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "59762-0935", "generic_name": "Voriconazole", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Voriconazole", "active_ingredients": [{"name": "VORICONAZOLE", "strength": "40 mg/mL"}], "application_number": "NDA021630", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20131216", "listing_expiration_date": "20271231"}